Prince Pharmaceutical Co (ROCO:6935) Total Debt per Share: NT$10.81 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6935 Prince Pharmaceutical Co Ltd ROCO:6935
62 GF Score
Price NT$28.50
GF Value NT$42.49
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Prince Pharmaceutical Co Total Debt per Share?

Prince Pharmaceutical Co ROCO:6935 62 Total Debt per Share is NT$10.81 as of Jun. 2026. GuruFocus rates ROCO:6935 with a GF Score™ of 62/100 and a GF Value™ of NT$42.49 (Significantly Undervalued). The stock has 2 warning signs investors should review.

NT$10.81 (As of Jun. 2026)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Prince Pharmaceutical Co's Total Debt Per Share for the quarter that ended in Jun. 2026 was NT$10.81.

Prince Pharmaceutical Co Total Debt per Share Historical Data

* Premium members only.

The historical data trend for Prince Pharmaceutical Co's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Prince Pharmaceutical Co Total Debt per Share Chart

Prince Pharmaceutical Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Debt per Share
Get a 7-Day Free Trial 15.49 14.32 13.42 12.47 11.17

Prince Pharmaceutical Co Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Total Debt per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.95 12.47 11.93 11.17 10.81
ROCO:6935
62GF Score
Prince Pharmaceutical Co Ltd ROCO:6935
Total Debt per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Prince Pharmaceutical Co Total Debt per Share Calculation

Prince Pharmaceutical Co's Total Debt Per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(354+68)/38
=11.17

Prince Pharmaceutical Co's Total Debt Per Share for the quarter that ended in Jun. 2026 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(339+69)/38
=10.81

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Debt per Share →
What does a Total Debt per Share of NT$10.81 mean?
Prince Pharmaceutical Co (ROCO:6935) has a Total Debt per Share of NT$10.81 as of Jun. 2026. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on Prince Pharmaceutical Co and its competitors.
Is Prince Pharmaceutical Co's Total Debt per Share too high?
Prince Pharmaceutical Co's current Total Debt per Share is NT$10.81. Overall, Prince Pharmaceutical Co has a GF Score™ of 62/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Prince Pharmaceutical Co's Total Debt per Share compare to ZTS?
Prince Pharmaceutical Co's Total Debt per Share of NT$10.81 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Debt per Share for a Drug Manufacturers company?
A good Total Debt per Share depends on the Drug Manufacturers industry context. However, Total Debt per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Debt per Share mean?
A high Total Debt per Share can signal that a stock is expensive relative to its fundamentals. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on Prince Pharmaceutical Co and its competitors. Prince Pharmaceutical Co's current Total Debt per Share is NT$10.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prince Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Prince Pharmaceutical Co (ROCO:6935) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$42.49, compared to a current price of NT$28.50 — trading 32.9% below its estimated fair value. The current Total Debt per Share is NT$10.81. Prince Pharmaceutical Co's overall GF Score™ is 62/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Debt per Share calculated?
Total Debt per Share is calculated from a company's financial statements. For Prince Pharmaceutical Co (ROCO:6935), the current Total Debt per Share is NT$10.81 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Prince Pharmaceutical Co (ROCO:6935) Overvalued in 2026?

Based on GuruFocus' analysis, Prince Pharmaceutical Co stock appears to be undervalued. The current stock price of NT$28.50 is trading 32.9% below its estimated GF Value™ of NT$42.49. GuruFocus considers Prince Pharmaceutical Co to be Significantly Undervalued.

Key valuation signals for ROCO:6935:

  • Total Debt per Share: NT$10.81
  • GF Value™: NT$42.49 vs. price of NT$28.50 (32.9% below fair value)
  • GF Score™: 62/100 with 2 warning signs

No single metric tells the full story. See the ROCO:6935 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Prince Pharmaceutical Co Business Description

Address Number 168, Keyunnan Road, Huwei Town, Yunlin, TWN, 632
Prince Pharmaceutical Co Ltd is engaged in the manufacturing, packaging, processing, and trading of various active pharmaceutical ingredients and health supplements. The company supplies its products to Taiwan, Japan, Spain, Europe and other regions.
62GF Score

Get the complete analysis for ROCO:6935

Total Debt per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$28.50
Price
NT$42.49
GF Value